Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)
Clinical trial NCT06417853 · COMPLETED
Trial details
- NCT number
- NCT06417853
- Sponsor
- Vaxxas Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-01-30
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.